Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To evaluate the dose-response relationship of the recombinant glucagon-like peptide-1 (7-36) amide (rGLP-1) administered by continuous subcutaneous infusion (CSCI) in subjects with type 2 diabetes, with respect to reductions in fasting, postprandial and 11-h serum glucose profiles.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Diabetes, Obesity and Metabolism |
Vol/bind | 13 |
Udgave nummer | 7 |
Sider (fra-til) | 639-43 |
Antal sider | 5 |
ISSN | 1462-8902 |
DOI | |
Status | Udgivet - 2011 |
ID: 40246465